Prostate News Archive
04-May-2009
Gen-Probe, Diagnocure Amend Prostate Cancer Test Deal (GenomeWeb News)
NEW YORK (GenomeWeb News) ? Gen-Probe and DiagnoCure said this week that they have amended their 2003 license agreement regarding development and commercialization of a molecular diagnostic test for prostate cancer. US FDA approves OncoGenex's 2nd phase-3 trial design of OGX-011 to treat castrate resistant prostate cancer (PharmaBiz)
OncoGenex Pharmaceuticals, Inc has reached an agreement with the US Food and Drug Administration (FDA) on the design of a second phase-3 registration trial of OGX-011, its lead product candidate targeting castrate resistant prostate cancer (CRPC), via the Special Protocol Assessment (SPA) process. Vitamin E, Selenium and Soy Won't Prevent Prostate Cancer (HealthDay via Yahoo! News)
FRIDAY, May 1 (HealthDay News) -- Despite earlier promise, three nutrients - vitamin E, selenium and soy - do not seem to prevent prostate cancer in men with precancerous prostate lesions, Canadian researchers report. Yale president has surgery for prostate cancer (Boston Globe)
Yale president Richard Levin is recovering after what school officials say was successful surgery for prostate cancer.
Back to Prostate News Archive
